CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies
Background/Aims: The prognostic power of the levels of total CD44 and its isoform CD44v6 for patients with gastric cancer (GC) remains controversial. Therefore, our study aims to generalize the clinicopathological and prognostic significance of these two proteins in GC. Methods: A literature search...
Main Authors: | Min Fang, Junrong Wu, Xin Lai, Huaying Ai, Yifeng Tao, Bo Zhu, Lingsha Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2016-11-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/452570 |
Similar Items
-
CD44/CD24 Expression in recurrent gastric cancer: a retrospective analysis
by: Yong Ching-Shya, et al.
Published: (2012-07-01) -
The Role of CD44 in Disease Pathophysiology And Targeted Treatment
by: Andre R. Jordan, et al.
Published: (2015-04-01) -
CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer
by: Weiyan Hou, et al.
Published: (2022-10-01) -
Correlation of Soluble CD44 Expression in Saliva and CD44 Protein in Oral Leukoplakia Tissues
by: Ingrīda Čēma, et al.
Published: (2021-11-01) -
High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
by: Si D, et al.
Published: (2020-02-01)